Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

124.21 +2.12 (+1.74%)
Official Closing Price Updated: 7:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,179,430
Open 122.65
Bid (Size) 120.00 (3)
Ask (Size) 124.19 (4)
Prev. Close 122.09
Today's Range 122.56 - 124.31
52wk Range 96.06 - 124.83
Shares Outstanding N/A
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
How Is The Market Feeling About Novartis?
 
Via Benzinga
2 Dividend Stocks to Buy and Hold
These stocks look like they can weather almost any storm. 
Via The Motley Fool
Topics Artificial Intelligence Cannabis Government

Performance

YTD
+27.9%
+27.9%
1 Month
+4.9%
+4.9%
3 Month
+13.3%
+13.3%
6 Month
+17.8%
+17.8%
1 Year
+9.6%
+9.6%

More News

Read More
NOVARTIS AG-SPONSORED ADR (NYSE:NVS) Emerges as a Top Pick for Value Investors with Strong Fundamentals and Attractive Valuation
Via Chartmill
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate
Via Benzinga
P/E Ratio Insights for Novartis
Via Benzinga
Novartis Rides Bullish Retail Mood, Roche Faces Gloom Amid Swiss-US Trade Concerns
Via Stocktwits
Novartis Reportedly Eyeing To Acquire Avidity Biosciences: But Retail Expects Management To Sell Only At Significant Premium
Via Stocktwits
Novartis Sees Hope In Reducing Lifelong Treatment Burden For Autoimmune Blood Disorder
Via Benzinga
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Via Stocktwits
Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well
Via Stocktwits
Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva
Via Benzinga
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
Via Benzinga
2 Brilliant Vanguard Index Funds to Buy With $1,000 in August and Hold Forever
Via The Motley Fool
Topics ETFs
PTCT Earnings Beat but Sales Drop 4%
Via The Motley Fool
Topics Earnings
Monte Rosa (GLUE) Q2 Revenue Jumps 394%
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
Schrödinger (SDGR) Q2 2025 Earnings Transcript
Via The Motley Fool
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful
Via Stocktwits
Topics Earnings
Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal
Via Investor's Business Daily
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Hazelden Betty Ford Foundation Appoints Four New Members to Its Board of Trustees
Via Newsfile
15 regions chosen for groundbreaking effort to reduce cardiovascular disease
Via NewMediaWire
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs
Via Benzinga
Topics Economy Government World Trade
Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy
Via Benzinga
U.S. Current-Account Deficit Widens to $450 Billion Amid Trade Imbalances and Energy Imports
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 124.21
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 08/15/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS